AXA Partners Signs With Upptec to Automate the Claims Process
19.10.2021 09:00:00 EEST | Business Wire | Press release
AXA Partners Germany and the Swedish-based Insurtech company Upptec will partner up for AXA Partners claims automation roll-out. The partnership will be the first of its kind in Germany and the data-driven claims valuation will center around all household electronics for its initial implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005815/en/
AXA Partners Signs With Upptec to Automate the Claims Process (Graphic: Business Wire)
Upptec has implemented claims automation within home contents in most parts of Europe, but this will be the first customer in Germany to roll-out data-driven and automated claims valuation for electronics based on real time local data with full automation capabilities.
“We as AXA Partners are delighted to announce the integration of Upptec’s valuation solution into our claims process. This will allow us to quickly support our customers in replacing their most valued possessions directly to their home and bring the customer experience to the next level. We look forward to working with Upptec to optimize and automate claims handling in the German market for the benefit of the policyholder.” — explains Kirsten Wenz, TPA Manager Consumer Electronics, AXA Partners Germany.
“We are extremely proud to be delivering a claims valuation solution with real-time responses from the local market for AXA Partners. This is the start of a partnership with great potential, and we see many common objectives by digitizing and automating the claims process, - making it transparent, objective and fast for the German policyholders that will set new standards for digital claims in Germany.” – says Magnus Franck, CEO at Upptec.
About AXA Partners Germany
AXA Partners is part of the international AXA Group, headquartered in Paris, and is one of the world's leading assistance and insurance providers worldwide. With more than 1000 business partners all over the world AXA Partners is working on innovative solutions for more security and a better quality of life. Worldwide, AXA Partners has more than 9000 employees. With this strong network and service partners in more than 200 countries, AXA Partners provides its customers with reliable support in the event of a claim — around the globe, 24 hours a day, 365 days a year.
For more information visit: www.axapartners.de
About Upptec
Upptec wants to transform the world’s insurance industry by making digital claims simple, fast, and effortless. From the first notice of loss to settlement, we automate the claims processes. Since the start Upptec have reduced costs, increased efficiencies, and driven circularity in a sustainable way-of-thinking for partners and customers while at the same time providing the best digital consumer centric experience.
For more information visit: https://upptec.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211018005815/en/
Contact information
Press Contact - Upptec
Matilda Hansson
Upptec AB
pr@upptec.com
Press Contact – AXA Partners
Roxana Müller
AXA Partners | AXA Assistance Deutschland GmbH
presse@axa-assistance.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 04:00:00 EEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe ’s Coverage of ESCMID Global Congress 202617.7.2026 04:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 01:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-treat, high-impact sites, including the scalp, nails, palms and soles, compared with placebo.1-5 These data build on the topline results from the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled LATITUDE PsO 3001 and 3002 studies.2,6 In those studies, about 70% of patients treated with zasocitinib achieved static Physician Global Assessment (sPGA) 0/1 (clear or almost clear skin) at week 16, with a significantly greater Psoriasis Area and Severity Index (PASI) 75 response rate seen as early as w
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance17.7.2026 00:36:00 EEST | Press release
The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful placement, Merz has further diversified its funding base by
The Estée Lauder Companies Appoints Madeleine Boyd as Senior Vice President, Global Brand Communications16.7.2026 23:22:00 EEST | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Madeleine Boyd as Senior Vice President, Global Brand Communications, effective July 20, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716738393/en/ Photo by Esteban La Tessa As part of the company’s continued efforts to strengthen how its brands better connect with consumers, Ms. Boyd will establish and lead a newly integrated Global Brand Communications team. In this role, she will ensure the company’s diverse portfolio is anchored by a cohesive enterprise communications strategy, while accelerating bold, consumer-first storytelling that drives earned media, cultural relevance, and brand desirability. She will also strengthen creator engagement, helping the company’s brands gain attention where culture is being shaped. Ms. Boyd brings extensive experience spanning brand strategy, communications, consumer engagement, and cultural insight
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom